Page 33 - Cardiac testing for coronary artery disease in potential kidney transplant recipients

201 imaging and radionuclide ventriculography. American De Vriese 2009 {published data only (unpublished sought but not
Journal of Cardiology 1989;64(16):1017–21. [MEDLINE: used)}
2816731] ∗ De Vriese AS, De Bacquer DA, Verbeke FH, De Winter
Caglar 2006 {published data only} O, Franken PR, De Sutter JH, et al.Comparison of
∗ Caglar M, Mahmoudian B, Aytemir K, Kahraman the prognostic value of dipyridamole and dobutamine
S, Arici M, Kabakci G, et al.Value of 99mTc- myocardial perfusion scintigraphy in hemodialysis patients.
methoxyisobutylisonitrile (99mTc-MIBI) gated SPECT for Kidney International 2009;76(4):428–36. [MEDLINE:
the detection of silent myocardial ischemia in hemodialysis 19494798]
patients: clinical variables associated with abnormal test Derfler 1991 {published data only}
results. Nuclear Medicine Communications 2006;27(1): ∗ Derfler K, Kletter K, Balcke P, Heinz G, Dudczak R.
61–9. [MEDLINE: 16340725] Predictive value of thallium-201-dipyridamole myocardial
Camp 1990 {published data only} stress scintigraphy in chronic hemodialysis patients and
∗ Camp AD, Garvin PJ, Hoff J, Marsh J, Byers SL, transplant recipients. Clinical Nephrology 1991;36(4):
Chaitman BR. Prognostic value of intravenous dipyridamole 192–202. [MEDLINE: 1959245]
thallium imaging in patients with diabetes mellitus Dussol 2004 {published data only}
considered for renal transplantation. American Journal of ∗ Dussol B, Bonnet J-L, Sampol J, Savin B, De La Forte C,
Cardiology 1990;65(22):1459–63. [MEDLINE: 2353652] Mundler O, et al.Prognostic value of inducible myocardial
Cortigiani 2005 {published data only} ischemia in predicting cardiovascular events after renal
∗ Cortigiani L, Desideri A, Gigli G, Vallebona A, Terlizzi transplantation. Kidney International 2004;66(4):1633–9.
R, Giusti R, et al.Clinical, resting echo and dipyridamole [MEDLINE: 15458460]
stress echocardiography findings for the screening of renal Eschertzhuber 2005 {published data only}
transplant candidates. International Journal of Cardiology ∗ Eschertzhuber S, Hohlrieder M, Boesmueller C, Pomaroli
2005;103(2):168–74. [MEDLINE: 16080976] A, Steurer W, Junker T, et al.Incidence of coronary heart
Cottier 1990 {published data only} disease and cardiac events in patients undergoing kidney
∗ Cottier C, Pfisterer M, Muller-Brand J, Thiel G, Burkart F. and pancreatic transplantation. Transplantation Proceedings
Cardiac evaluation of candidates for kidney transplantation: 2005;37(2):1297–300. [MEDLINE: 15848702]
value of exercise radionuclide angiocardiography. European Feola 2002 {published data only}
Heart Journal 1990;11(9):832–8. [MEDLINE: 2226509] ∗ Feola M, Biggi A, Ribichini F, Rovere A, Vado A,
Camuzzini G, et al.Predicting cardiac events with TL201
Cross 1996 {published data only}
∗ Cross DS, Alagarsamy SH, Adams M, Esquivel-Avila JG, dipyridamole myocardial scintigraphy in renal transplant
recipients. Journal of Nephrology 2002;15(1):48–53.
Carson R, Ahmad M. Dobutamine stress echocardiography
for risk stratification in patients for renal transplantation [MEDLINE: 11936426]
[abstract no: 3967]. Circulation 1996;94. Fossati 2004 {published data only}
∗ Fossati N, Meacci L, Amorese G, Bellissima G, Pieri
Dahan 1995 {published data only}
∗ Dahan M, Legallicier B, Himbert D, Faraggi M, Aubry M, Nardi S, et al.Cardiac evaluation for simultaneous
pancreas-kidney transplantation and incidence of
N, Siohan P, et al.[Diagnostic value of myocardial thallium
stress scintigraphy in the detection of coronary artery cardiac perioperative complications: Preliminary
study. Transplantation Proceedings 2004;36(3):582–5.
disease in patients undergoing chronic hemodialysis]
[Valeur diagnostique de la scintigraphie myocardique au [MEDLINE: 15110601]
thallium sous stimulation dans la detection de la maladie Fujimoto 2006 {published data only}
coronarienne chez l’hemodialyse chronique]. Archives des ∗ Fujimoto N, Iseki K, Tokuyama K, Tamashiro M,
Maladies du Coeur et des Vaisseaux 1995;88(8):1121–3. Takishita S. Significance of coronary artery calcification
[MEDLINE: 8572857] score (CACS) for the detection of coronary artery disease
Dahan 1998 {published data only} (CAD) in chronic dialysis patients. Clinica Chimica Acta
∗ Dahan M, Viron BM, Faraggi M, Himbert DL, Legallicier 2006;367(1-2):98–102. [MEDLINE: 16413522]
BJ, Kolta AM, et al.Diagnostic accuracy and prognostic Fukui 2005 {published data only}
value of combined dipyridamole- exercise thallium imaging ∗ Fukui M, Mori Y, Takehana K, Masaki H, Motohiro M,
in hemodialysis patients. Kidney International 1998;54(1): Sakamoto N, et al.Assessment of coronary artery disease in
255–62. [MEDLINE: 9648086] hemodialysis patients with delayed systolic blood pressure
Dahan 2002 {published data only} response after exercise testing. Blood Purification 2005;23
∗ Dahan M, Viron BM, Poiseau E, Kolta AM, Aubry N, (6):466–72. [MEDLINE: 16282683]
Paillole C, et al.Combined dipyridamole-exercise stress Fuster 2000 {published data only}
echocardiography for detection of myocardial ischemia ∗ Fuster D, Magrina J, Ricart MJ, Pascual J, Laterza C,
in hemodialysis patients: An alternative to stress nuclear Setoain FJ, et al.Noninvasive assessment of cardiac risk
imaging. American Journal of Kidney Diseases 2002;40(4): in type I diabetic patients being evaluated for combined
737–44. [MEDLINE: 12324908] pancreas-kidney transplantation using dipyridamole-
Cardiac testing for coronary artery disease in potential kidney transplant recipients (Review) 31
Copyright © 2011 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.